The utility of novel outcome measures in a naturalistic evaluation of schizophrenia treatment
Tamara Tompsett,1 Kate Masters,1,2 Parastou Donyai1 1Department of Pharmacy, University of Reading, Reading, UK; 2Department of Pharmacy, Berkshire Healthcare NHS Foundation Trust, Reading, UK Background: A number of naturalistic studies have investigated paliperidone palmitate (PP) using proxy me...
Guardado en:
Autores principales: | Tompsett T, Masters K, Donyai P |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d225ce3f01b4492b99e776fe3b42de58 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The social functional outcome of being naturalistically treated with paliperidone extended-release in patients with schizophrenia
por: Nakagawa R, et al.
Publicado: (2015) -
A naturalistic comparison of the efficacy and safety of intramuscular olanzapine and intramuscular levomepromazine in agitated elderly patients with schizophrenia
por: Suzuki H, et al.
Publicado: (2013) -
Measurement of treatment adherence with antipsychotic agents in patients with schizophrenia
por: Xinhua S Ren, et al.
Publicado: (2009) -
Evaluating depressive symptoms in mania: a naturalistic study of patients with bipolar disorder
por: Young AH, et al.
Publicado: (2015) -
The clinical utility of lurasidone in schizophrenia: patient considerations
por: Harvey PD
Publicado: (2015)